2-bromopalmitate reduces senescence phenotype in human cells by modulating palmitoylation

A new research paper was published in Aging (listed by MEDLINE/PubMed as “Aging (Albany NY)” and “Aging-US” by Web of Science), Volume 16, Issue 16 on August 23, 2024, entitled, “2-Bromopalmitate treatment attenuates senescence phenotype in human adult cells – possible role of palmitoylation.”

Morning Rounds: Women with sickle cell are sterilized postpartum more than others

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning! The First Opinion Podcast is

October 2, 2024

ACIP Votes to ‘Harmonize’ Dosing and Interval for Meningococcal B Vaccines

The CDC’s Advisory Committee on Immunization Practices (ACIP) on Thursday unanimously endorsed revising the dosing and interval of the meningococcal group B vaccine MenB-4C (Bexsero).

October 25, 2024

Compounders’ motion for preliminary injunction denied in case over tirzepatide shortage

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

March 12, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.